Aurora Cannabis Inc. (NASDAQ: ACB) Named to TIME Canada’s Best Companies 2026 List

EDMONTON, AB — July 9, 2026 — Leads & Copy — Aurora Cannabis Inc. has been recognized on TIME Canada’s Best Companies 2026 list, marking a historic achievement as the first and only cannabis company to receive this distinction. The award highlights the company’s strong performance and dedication to excellence within the industry.

The prestigious list, a collaboration between TIME and Statista, identified top Canadian companies based on rigorous evaluation criteria. To be considered, companies needed to have at least US$100 million in revenue in 2024 or 2025 and demonstrate positive revenue growth over three consecutive years, assessing both relative and absolute growth. The final ranking was determined by factors including employee satisfaction, revenue growth, and sustainability transparency, with only 125 companies making the cut.

“This is a proud milestone for Aurora and a meaningful recognition of our leadership strength in Canada,” said Miguel Martin, CEO & Executive Chairman of Aurora. “Above all, this recognition belongs to our people. Every day, our teams bring deep expertise, care and commitment to advancing medical cannabis globally, and being named to TIME’s Canada’s Best Companies 2026 list is a powerful signal of the progress we’ve made, the credibility we’ve earned, and the standard we continue to set.”

The recognition underscores Aurora’s people-first culture and its ongoing investment in fostering a supportive and empowering workplace. Through initiatives focused on leadership development, employee wellness, and community engagement, Aurora has cultivated a culture rooted in its values and driven by its purpose, “Opening the World to Cannabis™.” As the sole cannabis company to be named to TIME’s Canada’s Best Companies list, this achievement reinforces Aurora’s commitment to its employees and its role in advancing the global medical cannabis sector.

Aurora, a global leader in medical cannabis, focuses on enhancing lives through scientific expertise, proven performance, and a commitment to patient care. The company serves medical markets in Canada, Europe, Australia, and New Zealand with a portfolio of brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. Aurora operates world-class GMP-certified manufacturing facilities in Canada and Germany and aims to expand its global reach and deliver high-quality cannabis products.

Source: Aurora Cannabis Inc.

×

Welcome!

CannabisReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy

By Subscribing you will receive Daily Cannabis Story Leads via email 10:30 am ET Mon-Fri.